News and Trends 7 Dec 2023 BIO-Europe 2023: top ten highlights …rare diseases. Badura highlighted the importance of collaboration in developing large databases that can aid in understanding diseases and identifying potential biomarkers. Patient privacy and ethical concerns were also addressed,… December 7, 2023 - 24 minutesmins - By Dylan Kissane Share WhatsApp Twitter Linkedin Email
Podcast 10 May 2024 Cytokinetics’ cardiovascular pipeline beats strong …meaningful impact.” Cardiovascular diseases in some figures According to the World Health Organization, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each… May 10, 2024 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jun 2022 Gemelli Biotech to work on gastrointestinal diseases with new $19M funding U.S.-headquartered Gemelli Biotech Corp, which focuses on precision diagnostics for gastrointestinal (GI) diseases, has completed a $19 million series A finance round. Blue Ox Healthcare Partners, a private equity firm… June 23, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2022 Kamari Pharma raises $8M in investment for development of drugs for skin diseases …had been invested in Kamari Pharma. The company develops topical and oral drugs based on proprietary small molecules that inhibit an ion channel designated TRPV3. Dermatological diseases These innovative drugs… September 19, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Podcast 24 Nov 2023 Company exits stealth to launch molecular gates …4,000 of those are extracellular proteins, and about 1,000 of those are linked to disease. So the types of diseases that are caused by extracellular proteins include diseases where, for… November 24, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2022 Financing round of $21M completed for drug to treat autoimmune diseases …entered into the worldwide agreement for the investigational anti-CD38 monoclonal antibody, CID-103, for the treatment, prevention, and diagnosis of autoimmune diseases, conditions, and disorders in humans. Strong activity CID-103 is… July 11, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Mar 2024 Eight biotechnology universities in Germany cultivating future leaders …life sciences industry. This program provides an interdisciplinary education with a focus on substance research, bioinformatics, and biophysical chemistry. It addresses questions related to molecular changes and diseases, combining knowledge… March 8, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 29 Sep 2022 Human cells can now help scientists accelerate cure for neurodegenerative diseases Cell products providing a scalable source of human cells can now help scientists study neurogenerative diseases in human context. UK-based, cell-coding company, bit.bio announced the expansion to its portfolio today… September 29, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Apr 2024 5 RNA editing companies you should know about …rare and common diseases. It is currently working on advancing its first therapeutic program, a best-in-class product candidate to treat the inherited genetic disease alpha-1 antitrypsin deficiency (AATD), as well… April 18, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 10 Aug 2022 GentiBio and Bristol Myers Squibb to develop engineered Treg therapies for inflammatory bowel diseases …with inflammatory bowel diseases (IBD). The collaboration brings together GentiBio’s engineered Treg platform for generating scalable, stable, highly-selective, and durable Tregs with Bristol Myers Squibb’s capacity in cell therapies and… August 10, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jun 2023 Beacon Therapeutics launches with $120M to develop gene therapies for retinal diseases Beacon Therapeutics Holdings Limited has been launched to develop gene therapies to treat a range of rare and prevalent retinal diseases that result in blindness. Syncona Limited, with additional investors… June 12, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Feb 2018 Money, Money, Money! Europe’s Best-Funded Biotechs in 2018 …leading T cell receptor (TCR) biotech company. With proprietary TCR technology, the company develops novel first-in-class biological therapies to treat a wide range of diseases including cancer, autoimmune diseases, and… February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt Share WhatsApp Twitter Linkedin Email